JURA Bio Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 10

JURA Bio General Information

Description

Developer of AI foundation models designed to accelerate therapeutic discovery and development. The company integrates machine learning, synthetic biology, and high-throughput experimentation through iterative cycles of design, synthesis, and screening to produce proprietary functional data, enabling biopharmaceutical researchers to discover and develop novel therapeutic candidates across antibodies, peptides, enzymes, T-cell engagers, and other emerging modalities.

Contact Information

Website
www.jurabio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 100 Morrissey Boulevard
  • Boston, MA 02125
  • United States
+1 (216)
Primary Industry
Drug Discovery
Corporate Office
  • 100 Morrissey Boulevard
  • Boston, MA 02125
  • United States
+1 (216)

JURA Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

JURA Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
6. Accelerator/Incubator Completed Generating Revenue
5. Accelerator/Incubator 19-Oct-2023 Completed Generating Revenue
4. Later Stage VC 21-Sep-2023 Completed Generating Revenue
3. Later Stage VC (Series A) 29-Mar-2022 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view JURA Bio’s complete valuation and funding history, request access »

JURA Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view JURA Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

JURA Bio Patents

JURA Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026060280-A1 Methods enabling in vitro sampling of biological sequence models and synthesis of biological molecule libraries at petascales Pending 12-Sep-2024
WO-2023235856-A1 Apoptosis resistant immune cells with major histocompatibility complex chimeric antigen receptor Inactive 03-Jun-2022
AU-2018365080-A1 Major histocompatibility complex-based chimeric receptors and uses thereof for treating autoimmune diseases Active 10-Nov-2017
AU-2018365080-B2 Major histocompatibility complex-based chimeric receptors and uses thereof for treating autoimmune diseases Active 10-Nov-2017
AU-2025252604-A1 Major histocompatibility complex-based chimeric receptors and uses thereof for treating autoimmune diseases Pending 10-Nov-2017 C07K14/70521
To view JURA Bio’s complete patent history, request access »

JURA Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

JURA Bio Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Massachusetts Biomedical Initiatives Accelerator/Incubator
Fontus Capital Venture Capital Minority
Angel (individual) Minority
Massachusetts Life Sciences Center Government Minority
Angel (individual) Minority
You’re viewing 5 of 10 investors. Get the full list »

JURA Bio FAQs

  • When was JURA Bio founded?

    JURA Bio was founded in 2017.

  • Where is JURA Bio headquartered?

    JURA Bio is headquartered in Boston, MA.

  • What is the size of JURA Bio?

    JURA Bio has 13 total employees.

  • What industry is JURA Bio in?

    JURA Bio’s primary industry is Drug Discovery.

  • Is JURA Bio a private or public company?

    JURA Bio is a Private company.

  • What is JURA Bio’s current revenue?

    The current revenue for JURA Bio is .

  • How much funding has JURA Bio raised over time?

    JURA Bio has raised $32.6M.

  • Who are JURA Bio’s investors?

    Massachusetts Biomedical Initiatives, Fontus Capital, , Massachusetts Life Sciences Center, and are 5 of 10 investors who have invested in JURA Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process